Barrott L, Wiseman T, Tsianakas V, Czuber-Dochan W. Nurse and pharmacist systemic anti-cancer therapy review clinics and their impact on patient experience and care: A systematic review. Journal of Advanced Nursing. 2022; 79:(2)442-453

Lemanska L, Andrews C, Fisher L A National Audit of Pancreatic Enzyme Prescribing in Pancreatic Cancer from 2015 to 2023 in England Using OpenSAFELY-TPP. Semin Oncol Nurs. 2023; 39:(3)

McMenamin E, Kellermann M, Cunningham R, Selway J. Predictors of nurse practitioner prescription of opioids for cancer pain: quantitative results. J Adv Pract Oncol. 2023; 14:(1)22-35

Prescribing in cancer care

02 November 2023
Volume 5 · Issue 11


Deborah Robertson provides an overview of recently published articles that may be of interest to non-medical prescribers. Should you wish to look at any of the papers in more detail, a full reference is provided

Last month, the research round-up provided you with an overview of articles focusing on prescribing in countries outside of the UK to try and gain a more global perspective on nurse prescribing practices. This month, we will examine a range of articles looking at prescribing in various aspects of cancer care. The first is a systematic review of the impact of nurse and pharmacist clinics with patients on anti-cancer medication, their care and experience. The second is a quantitative piece looking at nurse prescribing of opioids in cancer pain. Finally, we conclude with a review of pancreatic enzyme prescribing in the form of a national audit.

This article, published in the Journal of Advanced Nursing, sought to review the evidence surrounding nurse and pharmacist review of patients undergoing systemic anti-cancer therapy (SACT).

This systematic review of the literature was carried out using a robust protocol and incorporating the population, exposure and outcome (PEO) framework to manage the search strategy. The review took place in April 2022 and searched seven appropriate and respected databases. No timescales were set to capture the progress of this intervention from early evidence to current day. The outcomes measured were patient experience and care from a pharmacist or nurse-led interventional review. Robust inclusion and exclusion criteria were applied, and the quantitative data extracted converted to textual description, with the qualitative data subjected to appropriate thematic analysis. In total, 15 studies met the criteria for inclusion and after quality appraisal and thematic analysis, three main themes emerged with some clear sub-themes.

Register now to continue reading

Thank you for visiting Journal of Prescribing Practice and reading some of our peer-reviewed resources for prescribing professionals. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to our clinical or professional articles

  • New content and clinical newsletter updates each month